Long-term BP analytics Hilo focuses on long-term blood pressure insights and pattern recognition rather to single readings, presenting a sales opportunity to position to clinics, hospitals, and insurers that require continuous monitoring solutions and long-term patient engagement.

US market expansion With the launch of Hilo Core in the United States and FDA-cleared cuff integration, there is a clear opportunity to target U.S. healthcare providers, health systems, and employers seeking comprehensive, regulatory-compliant home BP management solutions.

Clinical validation credibility Having 14 clinical studies and four validation studies, plus TIME Best Inventions recognition, provides strong proof points for partnerships with healthcare networks, researchers, and payer programs evaluating digital BP management technologies.

Funding momentum Recent Series B extension funding and high-profile backers (Dell Family Office) signals growth capacity and potential for co-development deals, strategic partnerships, and accelerated go-to-market arrangements with larger health tech players.

Global reach & adaptations Active in EU, UK, Canada, Australia with ongoing development of cuffless continuous BP tech in Switzerland, enabling partnerships across multinational employers, eHealth platforms, and telemedicine providers seeking global-compatible BP solutions.